Выпуск 4-98, 2020

Оригинальная статья

Lung Pathology in Patients with Acute Respiratory Distress Syndrome Associated with the Novel SARS-Cov-2 Virus

1 Barberán J., 2 Ortiz G., 3 Cardinal-Fernández P.

1 HM Monteprincipe University Hospital, San Pablo CEU University. Madrid, Spain
2 Universidad del Bosque. Bogotá, Colombia
3 HM Sanchinarro University Hospital, HM International Department. Madrid, Spain


Acute Respiratory Distress Syndrome (ARDS) is a well-recognized clinical problem first described in the late sixties. However,its relevance seems to have increased since the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) outbreak,as 14% (CI 95% 2% to 59%) of patients admitted to the hospital present with this syndrome.Conceptually, a syndrome is a group of symptoms and signs that correspond to several diseases. Although defining diseaseis much harder than may appear at first glance, we can view it as the association between a syndrome and a pathologypattern. Diffuse alveolar damage (DAD) is the morphological hallmark of ARDS, although studies performed inautopsies and patients have demonstrated that it is present in only half of ARDS patients. The SARS-CoV-2 outbreak andthe high incidence of ARDS associated with this infection have triggered a natural question: is the lung pathology similarin patients with ARDS associated with traditional risk factors than to SARS-CoV-2 infection?This review aims to analyze the lung pathology results of patients infected with the novel SARS-Cov-2. As this article targetsnon-intensive care physicians, we will first describe the main characteristics of the novel SARS-Cov-2 and the ARDSdefinition, and then the lung pathology results from the UCI in this group of patients.

КЛЮЧЕВЫЕ СЛОВА: coronavirus, SARS-Cov-2 infection, lung pathology, acute respiratory distress syndrome

ДЛЯ ЦИТИРОВАНИЯ: Barberán J., Ortiz G., Cardinal-Fernández P. Lung Pathology in Patients with Acute Respiratory Distress Syndrome Associated with the Novel SARS-Cov-2 Virus. Bulletin of Rehabilitation Medicine. 2020; 4 (98): 109–113. https://doi.org/10.38025/2078-1962-2020-98-4-109-113

Список литературы:

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.